NasdaqGS - Nasdaq Real Time Price USD
Centessa Pharmaceuticals plc (CNTA)
13.20
+0.94
+(7.67%)
At close: May 20 at 4:00:01 PM EDT
13.20
0.00
(0.00%)
After hours: May 20 at 4:31:54 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 5 |
| Avg. Estimate | -0.34 | -0.33 | -1.29 | -1.58 |
| Low Estimate | -0.37 | -0.35 | -1.36 | -1.81 |
| High Estimate | -0.3 | -0.31 | -1.22 | -1.34 |
| Year Ago EPS | -0.4 | -0.37 | -1.76 | -1.29 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 9 | 9 |
| Avg. Estimate | -- | 714.29k | 15M | -- |
| Low Estimate | -- | -- | 15M | -- |
| High Estimate | -- | 5M | 15M | -- |
| Year Ago Sales | -- | -- | -- | 15M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | -100.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.4 | -0.39 | -0.35 | -0.28 |
| EPS Actual | -0.4 | -0.37 | -0.58 | -0.2 |
| Difference | -0 | 0.02 | -0.23 | 0.08 |
| Surprise % | -0.84% | 4.52% | -64.76% | 28.57% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.34 | -0.33 | -1.29 | -1.58 |
| 7 Days Ago | -0.31 | -0.32 | -1.51 | -1.82 |
| 30 Days Ago | -0.31 | -0.32 | -1.51 | -1.82 |
| 60 Days Ago | -0.41 | -0.43 | -1.56 | -1.84 |
| 90 Days Ago | -0.41 | -0.43 | -1.55 | -1.84 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 3 | 2 |
| Up Last 30 Days | -- | -- | 3 | 2 |
| Down Last 7 Days | 1 | -- | -- | -- |
| Down Last 30 Days | 1 | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CNTA | 13.75% | 10.14% | 26.77% | -22.48% |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Initiated | Chardan Capital: Buy | 5/8/2025 |
| Initiated | Piper Sandler: Overweight | 3/31/2025 |
| Reiterates | Guggenheim: Buy to Buy | 3/26/2025 |
| Reiterates | Guggenheim: Buy to Buy | 2/10/2025 |
| Initiated | TD Cowen: Buy | 1/7/2025 |
| Maintains | Guggenheim: Buy to Buy | 11/15/2024 |
Related Tickers
PRAX Praxis Precision Medicines, Inc.
39.70
+6.29%
IDYA IDEAYA Biosciences, Inc.
19.63
+8.57%
ACLX Arcellx, Inc.
60.54
+3.47%
APGE Apogee Therapeutics, Inc.
40.34
+1.08%
DYN Dyne Therapeutics, Inc.
12.34
+5.83%
CRNX Crinetics Pharmaceuticals, Inc.
31.37
+1.36%
EWTX Edgewise Therapeutics, Inc.
14.87
+0.54%
TRML Tourmaline Bio, Inc.
16.20
-2.59%
VRDN Viridian Therapeutics, Inc.
13.82
+7.80%
PHVS Pharvaris N.V.
17.25
+3.36%